Literature DB >> 2708033

Effect of hydrazine sulfate on glucose-regulating enzymes in the normal and cancerous rat.

R Silverstein1, P Bhatia, D J Svoboda.   

Abstract

Glucokinase, hexokinase, fructose 1,6-bisphosphatase and phosphoenolpyruvate carboxykinase specific activities were monitored in liver cytosol from rats that had been made cancerous with 1,2-dimethylhydrazine and then treated with hydrazine sulfate. The presence of intestinal cancer, specifically, was confirmed by laparotomy and by histological analysis. Sustained changes in hexokinase and glucokinase specific activities were first evident during the latter weeks that the carcinogen was being administered. Upon subsequent treatment with hydrazine sulfate, glucokinase activity further decreased, and liver cytosolic phosphoenolpyruvate carboxykinase activity increased. Liver cytosolic hexokinase and fructose 1,6-bisphosphatase specific activities were not appreciably affected by the hydrazine sulfate treatment. These results indicate that hydrazine sulfate may influence carbohydrate metabolism at the level of selected liver enzymes not only with respect to gluconeogenesis, but also in terms of glucose uptake.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708033     DOI: 10.1016/0162-3109(89)90006-4

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  5 in total

1.  A biochemical and NMR spectroscopic study of hydrazine in the isolated rat hepatocyte.

Authors:  S Ghatineh; W Morgan; N E Preece; J A Timbrell
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

Review 2.  A review of the drug treatment of cachexia associated with cancer.

Authors:  B Gagnon; E Bruera
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

3.  Cancer-Associated Anorexia and Cachexia : Implications for Drug Therapy.

Authors:  C L Loprinzi; R M Goldberg; N L Burnham
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

4.  Key role of hydrazine to the interaction between oxaloacetic against phosphoenolpyruvic carboxykinase (PEPCK): ONIOM calculations.

Authors:  Pongthep Prajongtat; Darinee Sae-Tang Phromyothin; Supa Hannongbua
Journal:  J Mol Model       Date:  2013-04-27       Impact factor: 1.810

Review 5.  Is the pharmacological treatment of cancer cachexia possible?

Authors:  E Bruera
Journal:  Support Care Cancer       Date:  1993-11       Impact factor: 3.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.